Elanco Animal Health Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. Thank you all for joining us for the next session of the Barclays Global Healthcare Conference. And for this session, I have the pleasure of presenting Elanco and Todd Young, the Chief Financial Officer of Elanco, and most particularly delighted that this is Elanco's first participation in our conference. Todd, especially with you. And so as we recently wrapped up a least a couple of weeks ago, what is new with a couple of recaps that we can go into Q&A?
Sure. So Elanco continues to make very good progress with respect to our execution. 2022 was a very good year with respect to our innovation and the continued delivery of milestones and new products through the pipeline. And on our productivity and we're able to reduce our OpEx by over 10% and maintain a flagger patient declining there.
On the disappointing side, the portfolio didn't perform to the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
